Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Prostatic Neoplasms 4Breast Neoplasms 2Tongue Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Pain 1Lymphoid Interstitial Pneumonia 1Hot Flashes 1Chronic Disease 1Carcinoma, Intraductal, Noninfiltrating 1Breast Carcinoma In Situ 1

Interventions

Cisplatin 10Cetuximab 7Radiotherapy, Intensity-Modulated 5Radiotherapy 4Docetaxel 3Sorafenib 2Paclitaxel 2Fluorouracil 2Erlotinib Hydrochloride 2Celecoxib 2temsirolimus 1saracatinib 1ixabepilone 1cediranib 1adavosertib 1Zinc Oxide 1Vorinostat 1Vaccinium myrtillus extract 1Trioxsalen 1Taxes 1Standard of Care 1Soybean Proteins 1Sirolimus 1Ritonavir 1Practice Guidelines as Topic 1Platinum 1Phototherapy 1Photochemotherapy 1Observation 1N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Tongue Neoplasms × Soybean Proteins × Clear all
NCT02007200 2016-10-24

Soy Isoflavones in Preventing Head and Neck Cancer Recurrence in Patients With Stage I-IV Head and Neck Cancer Undergoing Surgery

National Cancer Institute (NCI)

Phase 2 Completed
55 enrolled 8 charts
Head & Neck

Lymphoid Interstitial Pneumonia, Squamous Cell Carcinoma of Head and Neck, Tongue Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡